$MRNA “Stock Sumo” Promoter Rank: 16/25 Moderna, Inc. Newsletter 7:03:27 AM August 4, 2022

on August 4, 2022 Newsletters and Tags: , , , , , , , , , , with 0 comments

Overall Perfomance for "Stock Sumo"

The following three charts can be used by potential investors to gauge the performance of "Stock Sumo":


242 out of 453 campaigns closed down on first day


171 out of 453 campaigns closed up on first day


40 out of 453 campaigns had no net effect

MRNA Promotional Newsletter

The following is a newsletter released by "Stock Sumo" promoting Moderna, Inc.


The following newsletter has not been verified for accuracy or completeness.

Clean Options Sweep
Amid a huge day for the markets yesterday, our daily options ideas also bore fruit. We've missed on exactly one of the many targets we've formulated all week, demonstrating a fairly routine level of accuracy for us. Our regular readers are surely accustomed to our high hit rate, and as for all of you newcomers, you will begin to see that we run a pretty tight ship around here. Each day consists of a review of the previous sessions interests, a grouping of fresh options ideas wherever possible, and an extended watchlist of both small and large cap stocks to watch based on their premarket activity.

brought three ideas for the day, and those targets were the MRNA Weekly $162.50-167.50 Calls, the SBUX Weekly $84-86 Calls, and the PYPL Weekly $98-101 Calls, with MRNA and SBUX both showing out as the big winners. Here are the intraday moves recorded by our designated plays

MRNA Weekly $162.50-167.50 Calls
$162.50 5.75-26.46 360%
$165 6.15-24.20 293%
$167.50 3.65-21.70 494%

SBUX Weekly $84-86 Calls
$84 1.22-4.00 228%
$85 .72-3.15 332%
$86 .37-2.28 516%

PYPL Weekly $98-101 Calls
$98 3.43-4.60 39%
$99 2.85-3.95 39%
$100 2.28-3.28 44%
$101 1.83-2.67 46%

Fresh Options Ideas
CI Weekly $277.50-282.50 Calls
COP Weekly $92-93 Calls
BABA Weekly $98-101 Calls
FTNT 0819 $56-55 Puts

Extended Watchlist

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. is to be read and fully agreed to before using our site, or joining our email list. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions, however any that may occur will be corrected as needed. BHS and its affiliates are not registered or licensed investment advisers, nor broker dealers. BHS cautions that the investments in companies profiled are commonly considered to be extremely high risk and use of any information provided is at the investor's sole risk.

Copyright 2022 StockServant.com,